GlassScriptPhysician profile
Pietro Bortoletto
NPI 1720477516
$37,707.82
in general payments reported to CMS, 2019-2025
8 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $51.19 · 2021: $49.75 · 2022: $1,278 · 2023: $133 · 2024: $15K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Education: $4,511 · Food and Beverage: $973 · Travel and Lodging: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,885.00 |
| Education | $4,511.32 |
| Food and Beverage | $972.92 |
| Travel and Lodging | $959.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Granata Bio Corporation | $13,162.50 | 2024-2025 | |
| Emd Serono, INC. | $11,322.00 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $6,444.44 | 2020-2025 | Menopur |
| Intuitive Surgical, INC. | $4,525.28 | 2024 | |
| Organon LLC | $1,272.03 | 2022-2025 | Ganirelix Acetate, Pregnyl |
| Rejoni INC. | $887.50 | 2024 | |
| Hamilton Thorne, INC. | $69.07 | 2025 | Guardia, Continuous Single Culturenx (Cscmnx), Cook |
| Coopersurgical, INC. | $25.00 | 2025 | Stripper |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pietro Bortoletto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.